Sarcopenia as a predictor of overall survival after cytoreductive nephrectomy for metastatic renal cell carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference34 articles.
1. Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor–targeted agents: results from a large, multicenter study;Heng;J Clin Oncol,2009
2. Development of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma;Margulis;Eur Urol,2013
3. Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status;Ohno;Int J Clin Oncol,2014
4. Improved survival in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy in the era of targeted therapy;Sakai;Int J Clin Oncol,2014
5. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model—a study based on data from an international multicentre project (EPCRC-CSA);Blum;Ann Oncol,2014
Cited by 96 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Influence of Body Composition on the Perioperative and Survival Outcomes of Renal Cell Carcinoma;Journal of Urologic Oncology;2023-11-30
2. Impact of sarcopenia on outcomes in surgical patients: a systematic review and meta-analysis;International Journal of Surgery;2023-09-07
3. Sarcopenia assessments as predictors of overall survival in patients with metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2023-09
4. Safety and efficacy of immune checkpoint inhibitors in advanced penile cancer: report from the Global Society of Rare Genitourinary Tumors;JNCI: Journal of the National Cancer Institute;2023-08-11
5. Low Skeletal Muscle as a Risk Factor for Worse Survival in Nonmetastatic Renal Cell Carcinoma with Venous Tumor Thrombus;Clinical Genitourinary Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3